1. Kinase drug discovery 20 years after imatinib: progress and future directions;Cohen;Nat Rev Drug Discov,2021
2. Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update;Roskoski;Pharmacol Res,2023
3. Application of radiomics in prognosing lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis;Wang;Cancers (Basel),2023
4. Bruton's tyrosine kinase inhibitors in the treatment of multiple sclerosis;Shulga;Postep Psychiatr Neurol,2023
5. Drugging hijacked kinase pathways in pediatric oncology: opportunities and current scenario;Candido;Pharmaceutics,2023